Generic placeholder image

Current Drug Safety


ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Hypocalcemia Induced by Raloxifene

Author(s): Thuy D.T. Vu, Suresh Varadarajan, Ego Seeman, George Jerums and Richard J. MacIsaac

Volume 7, Issue 2, 2012

Page: [176 - 178] Pages: 3

DOI: 10.2174/157488612802715654

Price: $65


Raloxifene is an anti-resorptive agent used in postmenopausal osteoporosis. This is the first report of the occurrence of clinically significant hypocalcemia following raloxifene treatment in a patient with occult vitamin D deficiency. Since vitamin D deficiency is widely prevalent in the community, screening for vitamin D deficiency and its correction is advisable before the initiation of anti-resorptive therapy.

Keywords: Hypocalcemia, raloxifene, vitamin D deficiency.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy